Prostate cancer
The study of compairing benefit of Abiraterone low versus full dose with Docetaxel in Prostate Cancer
Who can joinAdults
Age18+ years
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 9 Dec 2024. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Mahamana Pandit Madan Mohan Malaviya Cancer Centre (MPMMCC)Varanasi, Uttar PradeshDirections ↗
Registry summary (technical)
DAHLIA: Docetaxel with Abiraterone full versus low dose in Hormone SensitiveAdvanced Prostate Cancer – Phase III, Non-Inferiority Randomized Control OpenLabel Trial. - DAHLIA
Sponsor: Tata Memorial Hospital
CTRI/2023/03/050180 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 9 Dec 2024 · read by us 5 Nov 2026